Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-003544-37Phase 2Completed
Phase 2, randomised trial of levobupivacaine in arteriosclerosis obliterans (2 arms), sponsored by Aneurin Bevan University Health Board. Primary endpoint: Postoperative pain over first 5 days. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-003544-37.